Article 99. Rights and responsibilities of establishments conducting bioequivalence trial of drugs
Law 105/2016/QH13 — Luật Dược số 105/2016/QH13
Bioequivalence trial of drugs
1. An establishment conducting a bioequivalence trial of a drug has the following rights:
a/ To conduct the clinical research and biofluid analysis stages in the bioequivalence trial of a drug.
If the establishment only conducts the biofluid analysis, it may contract or cooperate with an establishment conducting clinical trial of drugs that satisfies the requirements of good clinical trial practices to conduct the clinical research in the bioequivalence trial;
b/ To conduct the bioequivalence trial under regulations;
c/ To import and buy chemicals, standard substances and drug samples to serve the bioequivalence trial;
d/ To use the results of the bioequivalence trial as agreed with the organization or individual having the drug put for bioequivalence trial.
2. An establishment conducting a bioequivalence trial of a drug has the following responsibilities:
a/ To take responsibility for the results of the bioequivalence trial with regard to the drug samples;
b/ To take responsibility for the safety of the person participating in the bioequivalence trial and pay compensation in accordance with law to him/her if any risk occurs due to its fault;
c/ To ensure truthfulness and objectivity in the bioequivalence trial;
d/ To be financially and organizationally independent from the organization or individual having the drug put for bioequivalence trial.
Article 99, Law 105/2016/QH13